#ASCO14 - Poster: Phase 1b study of abiraterone acetate and docetaxel in patients with metastatic castration-resistant prostate cancer

CHICAGO, IL USA (UroToday.com) - Presented by Scott T. Tagawa,1 Edwin M. Posadas,2 Justine Bruce,3 Emerson A. Lim,4 Daniel P. Petrylak,5 Weimin Peng,6 Scott Maul,6 Johan W. Smit,7 NamPhuong Tran,6 and David M. Nanus1 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

asco 2014 abiraterone tagawa thumb

 Click HERE to listen to an interview with Scott T. Tagawa, MD, one of the authors of this study

1Weill Cornell Medical College, New York, NY USA
2Cedars-Sinai Medical Center, Los Angeles, CA USA
3University of Wisconsin School of Medicine and Public Health, Madison, WI USA
4Columbia University Medical Center, New York, NY USA
5Yale Cancer Center, New Haven, CT USA
6Janssen Research & Development, Los Angeles, CA USA
7Janssen Research & Development, Beerse, Belgium

 

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Virtual Annual Meeting / Nov 13-14
  • 2020 Annual Virtual Meeting / Oct 17
  • 2020 Annual Congress / October 10 - 11
  • 2020 Annual Meeting / October 1-3
  • 2020 Virtual Congress / September 19-21
  • 2020 BCAN Think Tank Virtual / August 7
  • 2020 Virtual Education Program / August 8-10
  • 2020 Annual Meeting / July 17-19 / EAU Virtual Program
  • SUO - AUA 2020 Summer Webcast / July 18
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland